Awareness, Knowledge, and Current Practice of Breast Cancer Among Surgeons in Jordan

Breast cancer (BC) is the most prevalent cancer in Jordan. De-escalation in treatment reflects a paradigm shift in BC treatment. More tailored strategies and the adoption of a multidisciplinary approach are essential to apply recent changes in management. In the era of breast surgery fellowship, ado...

Full description

Saved in:
Bibliographic Details
Published inJCO global oncology Vol. 10; no. 10; p. e2300472
Main Authors Al-Balas, Mahmoud, Al-Balas, Hamzeh, Al-Amer, Zain, Ashour, Laith, Obiedat, Mufleh
Format Journal Article
LanguageEnglish
Published United States American Society of Clinical Oncology 01.06.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Breast cancer (BC) is the most prevalent cancer in Jordan. De-escalation in treatment reflects a paradigm shift in BC treatment. More tailored strategies and the adoption of a multidisciplinary approach are essential to apply recent changes in management. In the era of breast surgery fellowship, adopting well-structured training is essential to apply recent therapeutic guidelines and meet patients' expectations. A cross-sectional study using a customized, self-reported questionnaire was used. Data collection occurred anonymously using a link via WhatsApp in the period between February 2023 and April 2023. A total of 89 surgeons were involved in this study, and only 14 (15.7%) completed a subspecialty in breast surgery. About 58.4% considered the age of 40 years as the starting point for screening, and 84.3% reported that mammogram screening is associated with improved BC survival. Only 10.1% and 28.1% acknowledged the applicability of both tomosynthesis and breast magnetic resonance imaging in screening, respectively. A significant difference in the mean knowledge score about BC is observed between general surgeon and those with subspecialty. Varying levels of awareness concerning different risk factors and their correlation with the likelihood of BC occurrence observed. Although 56.2% of participants could offer breast conserving surgery and consider it oncological safe, only 48.3% defined it correctly. Of the participants, 61.8% and 76.4% stated that sentinel lymph node biopsy can be safely applied in clinically negative or suspicious axillary nodes, respectively, with <50% of surgeon performing it in their practice. More efforts are required to enhance the knowledge and practice of surgeons in the field of breast surgery. Adopting national guidelines can facilitate the acceptance and improvement of current practices among surgeons in Jordan.
AbstractList PURPOSEBreast cancer (BC) is the most prevalent cancer in Jordan. De-escalation in treatment reflects a paradigm shift in BC treatment. More tailored strategies and the adoption of a multidisciplinary approach are essential to apply recent changes in management. In the era of breast surgery fellowship, adopting well-structured training is essential to apply recent therapeutic guidelines and meet patients' expectations.METHODSA cross-sectional study using a customized, self-reported questionnaire was used. Data collection occurred anonymously using a link via WhatsApp in the period between February 2023 and April 2023.RESULTSA total of 89 surgeons were involved in this study, and only 14 (15.7%) completed a subspecialty in breast surgery. About 58.4% considered the age of 40 years as the starting point for screening, and 84.3% reported that mammogram screening is associated with improved BC survival. Only 10.1% and 28.1% acknowledged the applicability of both tomosynthesis and breast magnetic resonance imaging in screening, respectively. A significant difference in the mean knowledge score about BC is observed between general surgeon and those with subspecialty. Varying levels of awareness concerning different risk factors and their correlation with the likelihood of BC occurrence observed. Although 56.2% of participants could offer breast conserving surgery and consider it oncological safe, only 48.3% defined it correctly. Of the participants, 61.8% and 76.4% stated that sentinel lymph node biopsy can be safely applied in clinically negative or suspicious axillary nodes, respectively, with <50% of surgeon performing it in their practice.CONCLUSIONMore efforts are required to enhance the knowledge and practice of surgeons in the field of breast surgery. Adopting national guidelines can facilitate the acceptance and improvement of current practices among surgeons in Jordan.
PURPOSE Breast cancer (BC) is the most prevalent cancer in Jordan. De-escalation in treatment reflects a paradigm shift in BC treatment. More tailored strategies and the adoption of a multidisciplinary approach are essential to apply recent changes in management. In the era of breast surgery fellowship, adopting well-structured training is essential to apply recent therapeutic guidelines and meet patients' expectations. METHODS A cross-sectional study using a customized, self-reported questionnaire was used. Data collection occurred anonymously using a link via WhatsApp in the period between February 2023 and April 2023. RESULTS A total of 89 surgeons were involved in this study, and only 14 (15.7%) completed a subspecialty in breast surgery. About 58.4% considered the age of 40 years as the starting point for screening, and 84.3% reported that mammogram screening is associated with improved BC survival. Only 10.1% and 28.1% acknowledged the applicability of both tomosynthesis and breast magnetic resonance imaging in screening, respectively. A significant difference in the mean knowledge score about BC is observed between general surgeon and those with subspecialty. Varying levels of awareness concerning different risk factors and their correlation with the likelihood of BC occurrence observed. Although 56.2% of participants could offer breast conserving surgery and consider it oncological safe, only 48.3% defined it correctly. Of the participants, 61.8% and 76.4% stated that sentinel lymph node biopsy can be safely applied in clinically negative or suspicious axillary nodes, respectively, with <50% of surgeon performing it in their practice. CONCLUSION More efforts are required to enhance the knowledge and practice of surgeons in the field of breast surgery. Adopting national guidelines can facilitate the acceptance and improvement of current practices among surgeons in Jordan.
Breast cancer (BC) is the most prevalent cancer in Jordan. De-escalation in treatment reflects a paradigm shift in BC treatment. More tailored strategies and the adoption of a multidisciplinary approach are essential to apply recent changes in management. In the era of breast surgery fellowship, adopting well-structured training is essential to apply recent therapeutic guidelines and meet patients' expectations.PURPOSEBreast cancer (BC) is the most prevalent cancer in Jordan. De-escalation in treatment reflects a paradigm shift in BC treatment. More tailored strategies and the adoption of a multidisciplinary approach are essential to apply recent changes in management. In the era of breast surgery fellowship, adopting well-structured training is essential to apply recent therapeutic guidelines and meet patients' expectations.A cross-sectional study using a customized, self-reported questionnaire was used. Data collection occurred anonymously using a link via WhatsApp in the period between February 2023 and April 2023.METHODSA cross-sectional study using a customized, self-reported questionnaire was used. Data collection occurred anonymously using a link via WhatsApp in the period between February 2023 and April 2023.A total of 89 surgeons were involved in this study, and only 14 (15.7%) completed a subspecialty in breast surgery. About 58.4% considered the age of 40 years as the starting point for screening, and 84.3% reported that mammogram screening is associated with improved BC survival. Only 10.1% and 28.1% acknowledged the applicability of both tomosynthesis and breast magnetic resonance imaging in screening, respectively. A significant difference in the mean knowledge score about BC is observed between general surgeon and those with subspecialty. Varying levels of awareness concerning different risk factors and their correlation with the likelihood of BC occurrence observed. Although 56.2% of participants could offer breast conserving surgery and consider it oncological safe, only 48.3% defined it correctly. Of the participants, 61.8% and 76.4% stated that sentinel lymph node biopsy can be safely applied in clinically negative or suspicious axillary nodes, respectively, with <50% of surgeon performing it in their practice.RESULTSA total of 89 surgeons were involved in this study, and only 14 (15.7%) completed a subspecialty in breast surgery. About 58.4% considered the age of 40 years as the starting point for screening, and 84.3% reported that mammogram screening is associated with improved BC survival. Only 10.1% and 28.1% acknowledged the applicability of both tomosynthesis and breast magnetic resonance imaging in screening, respectively. A significant difference in the mean knowledge score about BC is observed between general surgeon and those with subspecialty. Varying levels of awareness concerning different risk factors and their correlation with the likelihood of BC occurrence observed. Although 56.2% of participants could offer breast conserving surgery and consider it oncological safe, only 48.3% defined it correctly. Of the participants, 61.8% and 76.4% stated that sentinel lymph node biopsy can be safely applied in clinically negative or suspicious axillary nodes, respectively, with <50% of surgeon performing it in their practice.More efforts are required to enhance the knowledge and practice of surgeons in the field of breast surgery. Adopting national guidelines can facilitate the acceptance and improvement of current practices among surgeons in Jordan.CONCLUSIONMore efforts are required to enhance the knowledge and practice of surgeons in the field of breast surgery. Adopting national guidelines can facilitate the acceptance and improvement of current practices among surgeons in Jordan.
Breast cancer (BC) is the most prevalent cancer in Jordan. De-escalation in treatment reflects a paradigm shift in BC treatment. More tailored strategies and the adoption of a multidisciplinary approach are essential to apply recent changes in management. In the era of breast surgery fellowship, adopting well-structured training is essential to apply recent therapeutic guidelines and meet patients' expectations. A cross-sectional study using a customized, self-reported questionnaire was used. Data collection occurred anonymously using a link via WhatsApp in the period between February 2023 and April 2023. A total of 89 surgeons were involved in this study, and only 14 (15.7%) completed a subspecialty in breast surgery. About 58.4% considered the age of 40 years as the starting point for screening, and 84.3% reported that mammogram screening is associated with improved BC survival. Only 10.1% and 28.1% acknowledged the applicability of both tomosynthesis and breast magnetic resonance imaging in screening, respectively. A significant difference in the mean knowledge score about BC is observed between general surgeon and those with subspecialty. Varying levels of awareness concerning different risk factors and their correlation with the likelihood of BC occurrence observed. Although 56.2% of participants could offer breast conserving surgery and consider it oncological safe, only 48.3% defined it correctly. Of the participants, 61.8% and 76.4% stated that sentinel lymph node biopsy can be safely applied in clinically negative or suspicious axillary nodes, respectively, with <50% of surgeon performing it in their practice. More efforts are required to enhance the knowledge and practice of surgeons in the field of breast surgery. Adopting national guidelines can facilitate the acceptance and improvement of current practices among surgeons in Jordan.
Author Obiedat, Mufleh
Al-Amer, Zain
Al-Balas, Mahmoud
Al-Balas, Hamzeh
Ashour, Laith
Author_xml – sequence: 1
  givenname: Mahmoud
  orcidid: 0000-0003-0291-2516
  surname: Al-Balas
  fullname: Al-Balas, Mahmoud
  organization: Department of General Surgery, Urology and Anesthesia, Faculty of Medicine, The Hashemite University, Zarqa, Jordan
– sequence: 2
  givenname: Hamzeh
  orcidid: 0000-0002-7332-2356
  surname: Al-Balas
  fullname: Al-Balas, Hamzeh
  organization: Department of General Surgery, Urology and Anesthesia, Faculty of Medicine, The Hashemite University, Zarqa, Jordan
– sequence: 3
  givenname: Zain
  surname: Al-Amer
  fullname: Al-Amer, Zain
  organization: Faculty of Medicine, Mu'tah University, Mu'tah, Jordan
– sequence: 4
  givenname: Laith
  surname: Ashour
  fullname: Ashour, Laith
  organization: Faculty of Medicine, Al-Balqa Applied University, Al-Salt, Jordan
– sequence: 5
  givenname: Mufleh
  surname: Obiedat
  fullname: Obiedat, Mufleh
  organization: Endocrine and General Surgery, Jordanian Royal Medical Services, Amman, Jordan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38905578$$D View this record in MEDLINE/PubMed
BookMark eNpNUV1vEzEQtFARLaVPvCM_ItEEf57txzSCUKgUJMqztWfvRVdd7GLnVPHvMU2peNrR7OzMSvOanKSckJC3nC25YOzjZrsUcsmYMuIFOROdNQvrFD_5D5-Si1rvGGNCdMY6_oqcSuuY1saekdvVAxRMWOsl_Zbyw4Rxh5cUUqTrubTNgX4vEA5jQJoHelUQ6oGuIQUsdLXPaUd_zGWHOVU6Jvo1lwjpDXk5wFTx4mmek5-fP92uvyxutpvr9epmEbjTYqHj0Ck0BqC3Ci0EYwdre60AIAglBUbNEfoopGSqc0EF6DvuGmGZ6aI8J9dH35jhzt-XcQ_lt88w-kcil52H0l6f0DvkxjlnnQGloFMNa6WcboGyi041r_dHr_uSf81YD34_1oDTBAnzXL1khjPbDnWTfjhKQ8m1Fhyeoznzf1vxm60X0j-20tTvnoznfo_xWfuvA_kHc7CGcA
Cites_doi 10.1056/NEJMoa020989
10.1080/02841860801971439
10.1001/jama.2019.10987
10.1002/bjs.5894
10.1148/radiol.2017161103
10.1186/bcr2331
10.1016/j.rcl.2016.12.013
10.1002/sim.1668
10.1097/00008469-200504000-00006
10.1214/19-STS729
10.1186/bcr281
10.1186/s12874-022-01694-7
10.1016/S0140-6736(12)61611-0
10.1002/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5
10.1245/s10434-009-0792-y
10.3322/caac.21660
10.1093/jnci/91.18.1541
10.1097/01.PRS.0000133200.99826.7F
10.1186/s13058-015-0653-5
10.1016/j.breast.2017.04.002
10.1097/00006534-200008000-00011
10.1016/S1470-2045(07)70278-4
10.1007/978-0-387-21842-7_8
10.1007/s13193-010-0014-x
10.1093/annonc/mdv107
10.1016/S1470-2045(18)30380-2
10.1056/NEJMoa2313487
10.1093/annonc/mds324
10.1001/jamaoncol.2023.3759
10.11613/BM.2021.010502
10.1016/j.jacr.2009.09.022
10.1007/s10549-008-9959-7
10.5306/wjco.v1.i1.1
10.1007/s10434-999-0671-6
10.1007/s00330-015-3807-z
10.1038/bjc.2016.32
10.1158/1055-9965.EPI-11-1196
10.1093/ije/27.5.735
10.1200/JCO.2007.15.3510
10.1097/RLI.0b013e3181f3fcdf
10.1200/JCO.2014.56.8626
10.1001/jama.2017.11470
10.3322/canjclin.57.2.75
10.1245/s10434-022-11866-w
10.5455/aim.2013.21.16-19
10.21037/tcr.2018.01.32
10.1056/NEJMoa022152
10.1016/j.breast.2012.12.009
10.1093/jnci/81.24.1879
10.1001/jamaoncol.2018.0174
10.1097/PRS.0b013e3181aee987
10.1148/radiol.2017161218
10.1002/jso.26301
10.6004/jnccn.2023.0046
10.1016/j.ejso.2006.10.010
10.1097/01.PRS.0000041441.42563.95
10.1111/tbj.12354
10.1200/JCO.22.01565
10.1200/JCO.20.03399
10.1148/rg.2021200101
10.1200/JGO.19.00279
10.1155/2022/3342910
10.1097/01.prs.0000187794.79464.23
10.1186/bcr1692
10.1002/cncr.31221
10.1016/S1470-2045(16)30067-5
10.1245/s10434-009-0765-1
10.1080/0284186X.2017.1403042
10.1200/JCO.2009.23.0839
10.1016/S1470-2045(14)70460-7
10.1093/jnci/djq088
10.1007/s10549-010-0951-7
10.1001/jamaoncol.2016.1025
10.1016/j.breast.2021.08.018
10.1016/j.hemonc.2016.08.001
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOA
DOI 10.1200/GO.23.00472
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
CrossRef
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2687-8941
ExternalDocumentID oai_doaj_org_article_9e17999897a44a6499954495f8836d94
10_1200_GO_23_00472
38905578
Genre Journal Article
GeographicLocations Jordan
GeographicLocations_xml – name: Jordan
GroupedDBID AAAAV
AAHPQ
AAIQE
AASCR
ABASU
ABDBF
ABDIG
ABVCZ
ACILI
ACXJB
ADGGA
ADHPY
ADPDF
AFDTB
AHQNM
AHVBC
AINUH
AJNWD
AJZMW
ALMA_UNASSIGNED_HOLDINGS
AMJPA
AMKUR
AMNEI
AOHHW
CGR
CUY
CVF
DIWNM
EBS
ECM
EEVPB
EIF
FBNNL
FCALG
GNXGY
GQDEL
GROUPED_DOAJ
H13
HLJTE
IKREB
M~E
NPM
OK1
OPUJH
OVD
OVDNE
OVEED
RLZ
RPM
RUC
TEORI
TSPGW
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c1952-5df64e77aab84e8ac78f88b54aaac2432ed51eabd2330469c4cab619bd28076d3
IEDL.DBID DOA
ISSN 2687-8941
IngestDate Tue Oct 22 15:12:34 EDT 2024
Sat Oct 26 04:53:05 EDT 2024
Thu Aug 22 14:42:02 EDT 2024
Sat Nov 02 12:03:26 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c1952-5df64e77aab84e8ac78f88b54aaac2432ed51eabd2330469c4cab619bd28076d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-0291-2516
0000-0002-7332-2356
OpenAccessLink https://doaj.org/article/9e17999897a44a6499954495f8836d94
PMID 38905578
PQID 3071086495
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_9e17999897a44a6499954495f8836d94
proquest_miscellaneous_3071086495
crossref_primary_10_1200_GO_23_00472
pubmed_primary_38905578
PublicationCentury 2000
PublicationDate 2024-Jun
2024-06-00
20240601
2024-06-01
PublicationDateYYYYMMDD 2024-06-01
PublicationDate_xml – month: 06
  year: 2024
  text: 2024-Jun
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle JCO global oncology
PublicationTitleAlternate JCO Glob Oncol
PublicationYear 2024
Publisher American Society of Clinical Oncology
Publisher_xml – name: American Society of Clinical Oncology
References b10
b54
b53
b12
b56
b11
b55
Savioli F (b60) 2021; 13
b13
Jordan Cancer Registry (b16)
b57
b15
b59
b18
b17
b19
b3
b4
b5
b6
b7
Nindrea RD (b33) 2017; 18
Centers for Disease Control and Prevention (b45) 2024
b61
b63
b62
b65
b20
b23
b22
b66
b25
b69
b24
b68
b27
Abdel-Razeq H (b2) 2018; 11
b26
b29
b28
Claus EB (b43) 1991; 48
b70
b72
b71
b30
b74
Jordanian Cancer Registry (b1) 2020
Sobin LH (b67) 2011
b73
b32
b76
b31
b75
b78
b77
b36
b35
b79
Sikov WM (b81) 2022
b38
Cheek JH (b14) 2002; 15
b37
b39
Jordan Ministry of Health (b8) 2019
b80
b83
b82
b41
b85
b40
b84
b87
b42
b86
b89
b44
b88
b47
Mysorekar V (b64) 2010; 1
b46
b49
b48
Francies FZ (b34) 2020; 10
Jordan RM (b58) 2022
b90
American Cancer Society (b52)
b91
b50
b51
References_xml – ident: b3
  doi: 10.1056/NEJMoa020989
– ident: b66
– ident: b54
  doi: 10.1080/02841860801971439
– ident: b36
  doi: 10.1001/jama.2019.10987
– ident: b79
  doi: 10.1002/bjs.5894
– ident: b31
  doi: 10.1148/radiol.2017161103
– volume: 18
  start-page: 3201
  year: 2017
  ident: b33
  publication-title: Asian Pac J Cancer Prev
  contributor:
    fullname: Nindrea RD
– ident: b50
  doi: 10.1186/bcr2331
– ident: b35
  doi: 10.1016/j.rcl.2016.12.013
– ident: b39
  doi: 10.1002/sim.1668
– ident: b47
  doi: 10.1097/00008469-200504000-00006
– ident: b40
  doi: 10.1214/19-STS729
– ident: b65
  doi: 10.1186/bcr281
– ident: b11
  doi: 10.1186/s12874-022-01694-7
– ident: b48
  doi: 10.1016/S0140-6736(12)61611-0
– volume: 15
  start-page: 154
  year: 2002
  ident: b14
  publication-title: Proc (Bayl Univ Med Cent)
  contributor:
    fullname: Cheek JH
– ident: b44
  doi: 10.1002/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5
– volume: 48
  start-page: 232
  year: 1991
  ident: b43
  publication-title: Am J Hum Genet
  contributor:
    fullname: Claus EB
– volume-title: Cancer Incidence in Jordan—2018
  ident: b16
  contributor:
    fullname: Jordan Cancer Registry
– ident: b5
  doi: 10.1245/s10434-009-0792-y
– ident: b12
  doi: 10.3322/caac.21660
– ident: b38
  doi: 10.1093/jnci/91.18.1541
– ident: b88
  doi: 10.1097/01.PRS.0000133200.99826.7F
– ident: b41
  doi: 10.1186/s13058-015-0653-5
– ident: b51
  doi: 10.1016/j.breast.2017.04.002
– ident: b86
  doi: 10.1097/00006534-200008000-00011
– volume-title: What Are the Risk Factors for Breast Cancer?
  year: 2024
  ident: b45
  contributor:
    fullname: Centers for Disease Control and Prevention
– ident: b6
  doi: 10.1016/S1470-2045(07)70278-4
– ident: b82
  doi: 10.1007/978-0-387-21842-7_8
– ident: b19
  doi: 10.1007/s13193-010-0014-x
– ident: b56
  doi: 10.1093/annonc/mdv107
– ident: b71
  doi: 10.1016/S1470-2045(18)30380-2
– ident: b72
  doi: 10.1056/NEJMoa2313487
– ident: b78
  doi: 10.1093/annonc/mds324
– ident: b68
  doi: 10.1001/jamaoncol.2023.3759
– volume-title: Cancer Incidence in Jordan 2016
  year: 2020
  ident: b1
  contributor:
    fullname: Jordanian Cancer Registry
– volume-title: Jordanian National Guidelines for Breast Cancer Management
  year: 2019
  ident: b8
  contributor:
    fullname: Jordan Ministry of Health
– ident: b10
  doi: 10.11613/BM.2021.010502
– ident: b23
  doi: 10.1016/j.jacr.2009.09.022
– volume-title: General Principles of Neoadjuvant Management of Breast Cancer
  year: 2022
  ident: b81
  contributor:
    fullname: Sikov WM
– ident: b59
  doi: 10.1007/s10549-008-9959-7
– volume: 1
  start-page: 1
  year: 2010
  ident: b64
  publication-title: World J Oncol
  doi: 10.5306/wjco.v1.i1.1
  contributor:
    fullname: Mysorekar V
– ident: b91
  doi: 10.1007/s10434-999-0671-6
– ident: b24
  doi: 10.1007/s00330-015-3807-z
– volume-title: Breast Cancer Conservation Therapy
  year: 2022
  ident: b58
  contributor:
    fullname: Jordan RM
– ident: b26
  doi: 10.1038/bjc.2016.32
– ident: b28
  doi: 10.1158/1055-9965.EPI-11-1196
– ident: b46
  doi: 10.1093/ije/27.5.735
– ident: b76
  doi: 10.1200/JCO.2007.15.3510
– ident: b25
  doi: 10.1097/RLI.0b013e3181f3fcdf
– ident: b29
  doi: 10.1200/JCO.2014.56.8626
– ident: b69
  doi: 10.1001/jama.2017.11470
– ident: b22
  doi: 10.3322/canjclin.57.2.75
– ident: b73
  doi: 10.1245/s10434-022-11866-w
– ident: b57
  doi: 10.5455/aim.2013.21.16-19
– ident: b53
  doi: 10.21037/tcr.2018.01.32
– ident: b4
  doi: 10.1056/NEJMoa022152
– ident: b63
  doi: 10.1016/j.breast.2012.12.009
– ident: b37
  doi: 10.1093/jnci/81.24.1879
– ident: b42
  doi: 10.1001/jamaoncol.2018.0174
– ident: b87
  doi: 10.1097/PRS.0b013e3181aee987
– ident: b27
  doi: 10.1148/radiol.2017161218
– ident: b77
  doi: 10.1002/jso.26301
– ident: b17
  doi: 10.6004/jnccn.2023.0046
– ident: b83
  doi: 10.1016/j.ejso.2006.10.010
– ident: b90
  doi: 10.1097/01.PRS.0000041441.42563.95
– volume: 10
  start-page: 1568
  year: 2020
  ident: b34
  publication-title: Am J Cancer Res
  contributor:
    fullname: Francies FZ
– ident: b49
  doi: 10.1111/tbj.12354
– ident: b70
  doi: 10.1200/JCO.22.01565
– ident: b80
  doi: 10.1200/JCO.20.03399
– ident: b20
  doi: 10.1148/rg.2021200101
– ident: b15
  doi: 10.1200/JGO.19.00279
– ident: b13
  doi: 10.1155/2022/3342910
– ident: b84
  doi: 10.1097/01.prs.0000187794.79464.23
– ident: b85
  doi: 10.1186/bcr1692
– ident: b61
  doi: 10.1002/cncr.31221
– ident: b7
  doi: 10.1016/S1470-2045(16)30067-5
– ident: b62
  doi: 10.1245/s10434-009-0765-1
– ident: b55
  doi: 10.1080/0284186X.2017.1403042
– ident: b30
  doi: 10.1200/JCO.2009.23.0839
– ident: b75
  doi: 10.1016/S1470-2045(14)70460-7
– volume-title: Breast-Conserving Surgery (Lumpectomy)
  ident: b52
  contributor:
    fullname: American Cancer Society
– volume-title: TNM Classification of Malignant Tumours
  year: 2011
  ident: b67
  contributor:
    fullname: Sobin LH
– ident: b18
  doi: 10.1093/jnci/djq088
– ident: b89
  doi: 10.1007/s10549-010-0951-7
– ident: b32
  doi: 10.1001/jamaoncol.2016.1025
– volume: 13
  start-page: 353
  year: 2021
  ident: b60
  publication-title: Breast Cancer (Dove Med Press)
  contributor:
    fullname: Savioli F
– ident: b74
  doi: 10.1016/j.breast.2021.08.018
– volume: 11
  start-page: 99
  year: 2018
  ident: b2
  publication-title: Hematol Oncol Stem Cell Ther
  doi: 10.1016/j.hemonc.2016.08.001
  contributor:
    fullname: Abdel-Razeq H
SSID ssj0002267891
Score 2.3045003
Snippet Breast cancer (BC) is the most prevalent cancer in Jordan. De-escalation in treatment reflects a paradigm shift in BC treatment. More tailored strategies and...
PURPOSE Breast cancer (BC) is the most prevalent cancer in Jordan. De-escalation in treatment reflects a paradigm shift in BC treatment. More tailored...
PURPOSEBreast cancer (BC) is the most prevalent cancer in Jordan. De-escalation in treatment reflects a paradigm shift in BC treatment. More tailored...
SourceID doaj
proquest
crossref
pubmed
SourceType Open Website
Aggregation Database
Index Database
StartPage e2300472
SubjectTerms Adult
Breast Neoplasms - diagnosis
Breast Neoplasms - surgery
Cross-Sectional Studies
Early Detection of Cancer
Female
Health Knowledge, Attitudes, Practice
Humans
Jordan - epidemiology
Male
Middle Aged
Practice Patterns, Physicians' - statistics & numerical data
Surgeons - statistics & numerical data
Surveys and Questionnaires
Title Awareness, Knowledge, and Current Practice of Breast Cancer Among Surgeons in Jordan
URI https://www.ncbi.nlm.nih.gov/pubmed/38905578
https://www.proquest.com/docview/3071086495
https://doaj.org/article/9e17999897a44a6499954495f8836d94
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LSwMxEA7Sg3gR366PEsGja9skm02OtfhA8QEq9BZmswnoYSu14t93Zncr9SBevIaEhJlh5ptJ5gtjx9Fr4zFOpIUOKkXvF1NrrEghxmgwgklVUEH_9k5fPavrcTZe-OqL3oQ19MCN4Ho2EGcZrs9BKdAE0DOFqD4aI3VpGybQvl1Ipl5rUhd0wnbQNuShJfQu708FkZmqXPwIQTVT_-_wsg4zF2tstcWHfNica50thWqDLd-2N-Cb7Gn4Se1b6J9O-M28HnbCoSp5S7XEH9rGJz6J_IzenM_4iHQ75UP6WYg_Uic0Ght_qfg15p5QbbHni_On0VXa_oyQ-oHNMHsso1YhzwEKo4IBnxuUR5EpAPBCSRHKbBCgKAWVK7T1ykOBqRIOmH6uS7nNOtWkCruMSwBhgyxiH2eBiqaUHoN-GYXx3hidsOO5sNxbQ4DhKHFAmbrLeyekq2WasDMS5PcUYq2uB1CXrtWl-0uXCTuaq8GhldPVBVRh8vHuJCEhgyuyhO00-vneCiEXEYmZvf84wj5bEQhbmsdgB6wzm36EQ4Qds6JbW1i3rgd9Ad830aU
link.rule.ids 315,783,787,867,2109,27936,27937
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Awareness%2C+Knowledge%2C+and+Current+Practice+of+Breast+Cancer+Among+Surgeons+in+Jordan&rft.jtitle=JCO+global+oncology&rft.au=Al-Balas%2C+Mahmoud&rft.au=Al-Balas%2C+Hamzeh&rft.au=Al-Amer%2C+Zain&rft.au=Ashour%2C+Laith&rft.date=2024-06-01&rft.issn=2687-8941&rft.eissn=2687-8941&rft.issue=10&rft_id=info:doi/10.1200%2FGO.23.00472&rft.externalDBID=n%2Fa&rft.externalDocID=10_1200_GO_23_00472
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2687-8941&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2687-8941&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2687-8941&client=summon